Methylphenylpiracetam

Methylphenylpiracetam is a nootropic drug of the racetam family. It is a derivative of piracetam, with the addition of a methyl group and a phenyl group. Methylphenylpiracetam is believed to have potential cognitive-enhancing effects, although research on its efficacy and safety is limited.

History

Methylphenylpiracetam was first synthesized in the 1980s as a more potent version of piracetam. It was developed in the Soviet Union and later in Russia, where it is currently marketed as a nootropic drug.

Pharmacology

Like other racetams, methylphenylpiracetam is believed to enhance cognitive function by modulating neurotransmitters in the brain. However, the exact mechanism of action is not fully understood. Some studies suggest that it may increase the density of acetylcholine receptors in the brain, which could potentially enhance memory and learning.

Clinical use

In Russia, methylphenylpiracetam is used as a prescription drug for cognitive enhancement. It is also used off-label for a variety of conditions, including Alzheimer's disease, Parkinson's disease, and stroke recovery. However, its use in these conditions is not supported by robust clinical evidence.

Safety and side effects

The safety profile of methylphenylpiracetam is not well-studied. Some users report side effects such as insomnia, anxiety, and irritability. There is also a potential for drug interactions, particularly with other nootropic drugs.

Legal status

In many countries, including the United States, methylphenylpiracetam is not regulated as a prescription drug. It is often sold online as a dietary supplement. However, its legal status may vary by country and it is advised to check local regulations before purchasing.

See also

• Piracetam
• Nootropic
• Racetam

• 
  E1R.svg